Epiq Capital II
Epiq Capital II is a concentrated India growth-equity fund backing late-stage technology and consumer businesses. Public manager and fund records identify Lenskart, Zepto, Giva, Bhanzu, Cure.fit, Pristyn Care, Dailyhunt and Park+ as attributable companies across the Epiq platform and current Fund II-era disclosures.
At a glance
- Founded
- 2016
- Footprint
- Mumbai
- Stage
- Growth equity; late-stage technology and consumer platforms
Research profile
Read the manager in sequence.
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
Epiq Capital II uses a growth equity; late-stage technology and consumer platforms approach across Consumer technology, SaaS, fintech, healthcare technology.
Current evidence
Epiq’s current 2026 website continues to identify its growth and late-stage mandate and portfolio founders, while 2025 prospectus records and the manager’s FY25 update identify ongoing Fund II-era holdings and activity.
Strategy
Growth equity; late-stage technology and consumer platforms
Sector focus
Consumer technology, SaaS, fintech, healthcare technology
Current signal
Epiq’s current 2026 website continues to identify its growth and late-stage mandate and portfolio founders, while 2025 prospectus records and the manager’s FY25 update identify ongoing Fund II-era holdings and activity.
Next step
Need this manager reviewed against your mandate?
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.